Ondansetron Aurobindo

Medicinal product

(Invented) name

Ondansetron Aurobindo

Active substance (s)

Ondansetronas

Strength

8 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A04AA01, Ondansetron

Marketing authorisation holder

UAB Actiofarma, Lietuva

Date of authorisation

2019-05-21

Date of renewal

Documents

0913-001_Ondansetron Aurobindo_2021-04-14.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Ondansetronas	8 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
101746	87851	1087851	lizdinė plokštelė	N10		Receptinis	LT/L/19/0913/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2024-08-31	Išregistruotas
2019-05-21	Registruotas